ImmunityBio, Inc. — Director's Dealing 2017

Sep 14, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2017-09-13

Reporting Person: GORLIN STEVE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-13	Common Stock	S	39604	$5.9269	Disposed	246280	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	521720	Indirect

Footnotes

F1: Represents the weighted average share price of an aggregate total of 39,604 shares sold in the price range of $5.90 to $5.955 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.